Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI Taiwan ETF (EWT) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance

iShares MSCI Taiwan ETFTrade
Kymera Therapeutics Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI Taiwan ETF vs Kymera Therapeutics Inc. Common Stock — how do they compare? iShares MSCI Taiwan ETF trades at $107.46 (market cap $12.49B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: iShares MSCI Taiwan ETF is the larger of the two by market cap, and iShares MSCI Taiwan ETF is trading nearer its 52-week high, Kymera Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Taiwan ETF for 53 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.

EWTKYMR
Market Cap
$12.49B$8.87B
Volume
5,965,495779,107
Sector
Broad Market / FactorHealth
52-Week High
$118.00$127.31
52-Week Low
$60.03$55.80
Typical Hold Time
53 Days0 Days
Enterprise Value
—$8.26B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI Taiwan ETF

EWT (iShares MSCI Taiwan ETF) trades at $113.46, down 0.71% on the day, with technical indicators showing a bullish trend from moving averages while oscillators remain neutral. The ETF maintains strong exposure to Taiwan's semiconductor sector, particularly TSMC, which represents 22.5% of holdings. Recent news highlights Taiwan's strategic position in AI chip manufacturing with companies planning $20 billion in US investments.

The ETF offers exposure to Taiwan's dominant semiconductor industry but faces significant geopolitical risks. Strong AI-driven fundamentals and reasonable tech valuations support upside potential, though China-Taiwan tensions represent a persistent overhang. Institutional interest remains positive with Bank of America increasing its stake by 22.4% in the latest quarter.

Kymera Therapeutics Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWT
100% Buy0% Sell
Avg holding period · 53 Days
KYMR
100% Buy0% Sell
Avg holding period · 0 Days

About iShares MSCI Taiwan ETF

EWT tracks the MSCI Taiwan 25/50 Index, providing targeted exposure to large and mid-cap companies in Taiwan. It is heavily concentrated in the information technology sector, serving as a liquid instrument for investors seeking a single-country view of Taiwan's export-oriented and tech-driven economy.

Read more on EWT →

About Kymera Therapeutics Inc. Common Stock

Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.

Read more on KYMR →